Cardinal Health

Cardinal Health Competitive Intelligence & Landscape

cardinalhealth.com ·

Overview

Cardinal Health Overview

Cardinal Health (cardinalhealth.com) is a global healthcare services and products company, headquartered in Dublin, Ohio. Established over 50 years ago, it is a crucial link in the healthcare supply chain, distributing pharmaceuticals and specialty products, manufacturing and distributing medical and laboratory products, and offering performance and data solutions for healthcare facilities.

The company's core services and products include pharmaceutical distribution, medical products and supplies (such as anesthesia, gloves, PPE, surgical supplies, and patient monitoring systems), laboratory services and solutions, and nuclear medicine. They also provide comprehensive healthcare solutions for various settings, including ambulatory surgery centers, hospitals, long-term care facilities, and retail independent pharmacies.

Cardinal Health additionally offers OptiFreight® Logistics and Presource® Procedural Packs and Solutions.

Cardinal Health targets a broad market within the healthcare industry, serving hospitals and health systems, pharmacies (including hospital, mail order, and home delivery), laboratories, manufacturers, payers, and specialty physician practices. With approximately 58,000 mission-driven partners globally and operations in over 30 countries, Cardinal Health emphasizes advancing healthcare and improving lives.

Their mission is encapsulated by the phrase “essential to care™,” indicating their integral role in supporting healthcare providers and patients.

Cardinal Health also focuses on sustainable business practices and an inclusive culture, with a commitment to meeting customer and patient needs while driving value creation for shareholders.

Cardinal Health

Cardinal Health Weekly Intel Updates

Receive weekly intel updates about Cardinal Health straight to your inbox.

Competitors

Cardinal Health Competitors

Cardinal Health faces strong competition in the healthcare solutions, logistics, and supplies market. One major direct competitor is McKesson Corporation. McKesson operates in the highly competitive pharmaceutical distribution and related healthcare services sector, directly vying with Cardinal Health for market share in wholesale distribution with a national reach [source] [source] [source]. Both companies compete on factors such as service offerings, support services, product line breadth, and price [source].

Another significant competitor is Cencora (formerly AmerisourceBergen). Like McKesson, Cencora is a major player in pharmaceutical distribution and healthcare services, making it a direct rival to Cardinal Health in the highly competitive environment of pharmaceutical and medical supply distribution [source] [source] [source]. Both Cencora and McKesson are frequently listed as top competitors, indicating their similar market positioning and comprehensive service portfolios that mirror those offered by Cardinal Health, which include medical and pharmaceutical products, supply chain management, and related services [source] [source].

Medline is also a key competitor for Cardinal Health, particularly in the development, manufacturing, and distribution of medical and surgical products [source] [source] [source]. While Cardinal Health offers a wide range of medical products and supplies, including anesthesia, infection control, and surgical equipment [source], Medline similarly focuses on medical technology and healthcare products. Their competition revolves around the breadth and quality of their product lines and distribution capabilities.

Other notable competitors include B. Braun, a medical technology company specializing in infusion therapy, pain management, and other healthcare products and services like smart infusion pumps and IV fluids, which overlaps with Cardinal Health's offerings in medical supplies [source]. Additionally, Owens & Minor is listed among top competitors, indicating its presence in similar segments of the healthcare supply chain [source]. These companies challenge Cardinal Health by providing alternative solutions across various aspects of healthcare delivery and supply.

Alternatives

Cardinal Health Alternatives

Product & Pricing

Cardinal Health Product and Pricing Intelligence

Cardinal Health provides a range of product and pricing intelligence solutions designed to enhance efficiency and reduce costs across the healthcare spectrum. One key offering is Cardinal Health Market℠, an online resource that allows users to find, evaluate, and make informed product decisions with accurate details, rich imagery, and side-by-side comparisons of clinically relevant items [cardinalhealth.com/en/solutions/cardinal-health-market.html]. While specific pricing plans for individual users of the Market are not detailed, its function suggests it serves as a central hub for customers to access product information and potentially manage orders, implying its integration within existing customer accounts or service agreements.

For specialty physician practices, Cardinal Health offers access to Group Purchasing Organizations (GPOs) such as VitalSource™ GPO, Cornerstone Rheumatology™ GPO, Acuity™ GPO, RPG™ GPO, MosaicGPO™ Solutions, and Traverse™ GPO [cardinalhealth.com/en/services/specialty-physician-practice/our-gpos.html]. These GPOs aggregate purchasing power, providing healthcare contracts and solutions aimed at improving financial performance and operational efficiencies for specialty clinics. This model offers cost savings through negotiated pricing on a wide array of products and services, acting as a direct cost-reduction strategy for members.

Cardinal Health also provides Presource® Kitting Services and Solutions, offering both custom and standard kits for common surgeries. These kits are presented as a low-cost, high-quality solution to improve cost-effectiveness by consolidating components typically purchased and managed separately [cardinalhealth.com/content/dam/corp/web/documents/catalog/cardinal-health-presource-standard-pack-catalog.pdf]. Furthermore, the company's own Cardinal Health™ Brand Products emphasize quality, consistency, and cost savings across various medical and laboratory supplies, helping providers manage their bottom line [cardinalhealth.com/en/product-solutions/medical.html; cardinalhealth.com/en/product-solutions/medical/laboratory-products/cardinal-health-brand-for-lab.html].

In the pharmaceutical supply chain, the Cardinal Health™ Intelogix™ Platform leverages artificial intelligence and machine learning to reshape the supply chain, ensuring access to critical medications and reducing costs for health systems [cardinalhealth.com/en/services/hospital-pharmacy/intelogix-platform.html; cardinalhealth.com/en/services/hospital-pharmacy.html]. For retail pharmacies, Cardinal Health provides solutions that include color planograms, market-comprehensive retail pricing with competitively priced private label and national brands, and customization options based on sales data and market insights [cardinalhealth.com/content/dam/corp/web/documents/catalog/cardinal-health-retail-pharmacy-2021-solutions-guide.pdf]. For oncology practices, the Regimen Analyzer allows for comparison of treatment regimens by clinical indication and cost, providing data-driven decisions and complete cost transparency to optimize patient outcomes and practice finances [cardinalhealth.com/en/services/specialty-physician-practice/solutions/regimen-analyzer.html]. While specific pricing tiers for these platforms are not publicly listed, they are presented as value-added services that integrate into existing relationships and contracts with Cardinal Health customers.

Hiring & Layoffs

Cardinal Health Hiring and Layoffs

Cardinal Health is actively hiring across a diverse range of critical functions to support its expansive healthcare solutions, logistics, and supply operations. The company consistently posts opportunities in its Warehouse & Manufacturing Operations, including roles like Warehouse Associate in various shifts and locations such as Columbus, OH, highlighting its continuous need for a robust supply chain workforce. These roles are essential for the company's daily operations, which serve over 60,000 facilities, showcasing a strong and consistent demand in this area [https://jobs.cardinalhealth.com/career-areas/warehouse].

Beyond its operational backbone, Cardinal Health also seeks talent in specialized and corporate areas. Recent job postings include a Software Engineer position with an anticipated closing date in May 2026, and a Data Analyst, Data Analytics role with an anticipated close in April 2026, indicating an investment in technology and data-driven strategies [https://jobs.cardinalhealth.com/search/jobdetails/software-engineer/75a7cdb1-fffe-49a2-8549-abfebe14b6c2, https://jobs.cardinalhealth.com/search/jobdetails/data-analyst-data-analytics/9903171e-dd4c-4bb1-b090-d3f5726e07ce]. These openings, alongside a wide array of corporate careers in areas like accounting/finance, human resources, and legal, demonstrate the company's commitment to maintaining a strong internal infrastructure as a Fortune 25 enterprise [https://jobs.cardinalhealth.com/career-areas/corporate].

The company's hiring patterns signal a strategic focus on enhancing its core capabilities in supply chain management, while simultaneously investing in technological advancements and robust corporate support.

Cardinal Health offers rewarding careers that allow individuals to make a positive impact, emphasizing its role as "the business behind healthcare" by making it more cost-effective [https://www.cardinalhealth.com/en/careers.html]. The inclusion of roles like Delivery Driver for Pharmacy Services also underscores its commitment to comprehensive healthcare delivery [https://jobs.cardinalhealth.com/].

Leadership

Cardinal Health Management and Leadership Team

The leadership team at Cardinal Health (cardinalhealth.com) is helmed by Jason Hollar, who serves as Chief Executive Officer, a position he has held since 2022, following his tenure as CFO from 2020 to 2022 [source] [source]. The Operating Committee includes key executives such as Aaron Alt, Chief Financial Officer, who manages financial strategy, capital deployment, and corporate development [source].

Further strengthening the leadership, Michelle Greene holds the role of Executive Vice President, Chief Information Officer, Global Technology and Business Services, driving technological innovation and service delivery [source].

Patrick Pope serves as Executive Vice President, General Counsel, overseeing the legal function, including corporate governance and litigation [source].

Debbie Weitzman is the Chief Executive Officer of the Pharmaceutical and Specialty Solutions Segment, while Steve Mason leads the Global Medical Products and Distribution segment as its Chief Executive Officer [source] [source].

Other notable members of the Operating Committee include Ben Brinker, President of Global Operations and Supply Chain, and Brad Cochran, President of Pharmaceutical & Specialty Distribution and President of The Medicine Shoppe International, Inc. [source]. The Board of Directors also features experienced individuals, with recent appointments including Robert W. Azelby in 2024, Michelle M. Brennan in 2022, and Sheri H. Edison and David C. Evans both in 2020 [source]. These leaders collectively drive Cardinal Health's mission to advance healthcare and improve lives as a global healthcare services and products company headquartered in Dublin, Ohio [source].

Financials

Cardinal Health Financial Performance, Fundraising, M&A

In fiscal year 2025, Cardinal Health reported a revenue of $222.6 billion, marking a 2% decrease from the previous year, primarily attributed to the expiration of OptumRx contracts within its Pharma segment, though partially offset by growth in branded and specialty pharmaceutical sales [cardinalhealth.com/content/dam/corp/web/documents/Report/cardinal-health-FY25-annual-report.pdf]. Despite this revenue dip, GAAP operating earnings for fiscal 2025 saw a significant 83% increase, reaching $2.275 billion [cardinalhealth.com/content/dam/corp/web/documents/Report/cardinal-health-FY25-annual-report.pdf]. The company's fiscal year 2025 adjusted free cash flow was $2.5 billion [newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results-and-Raises-Fiscal-Year-2026-Guidance].

Looking ahead, Cardinal Health has demonstrated a strong financial outlook, consistently raising its fiscal year 2026 non-GAAP EPS guidance. Initially, the guidance was set at $9.30 to $9.50 [newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results-and-Raises-Fiscal-Year-2026-Guidance], which was subsequently raised to $9.65 to $9.85 [newsroom.cardinalhealth.com/2025-10-30-Cardinal-Health-Reports-First-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook], then to at least $10.00 [newsroom.cardinalhealth.com/2026-01-13-Cardinal-Health-Raises-Fiscal-2026-Outlook-and-Highlights-Strategic-Progress-During-J-P-Morgan-Healthcare-Conference-Presentation], further to $10.15 to $10.35 [newsroom.cardinalhealth.com/2026-02-05-Cardinal-Health-Reports-Second-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook], and finally to $10.70 to $10.80 by the third quarter of fiscal year 2026 [newsroom.cardinalhealth.com/2026-04-30-Cardinal-Health-Reports-Third-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook]. This indicates robust financial health and positive growth expectations.

Quarterly results for fiscal year 2026 have shown consistent revenue growth. In the first quarter, revenue increased by 22% to $64 billion [newsroom.cardinalhealth.com/2025-10-30-Cardinal-Health-Reports-First-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook]. The second quarter saw a 19% increase in revenue to $65.6 billion [newsroom.cardinalhealth.com/2026-02-05-Cardinal-Health-Reports-Second-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook], and the third quarter reported an 11% revenue increase, reaching $60.9 billion [newsroom.cardinalhealth.com/2026-04-30-Cardinal-Health-Reports-Third-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook]. These figures highlight Cardinal Health's ability to drive revenue growth across its various segments.

Cardinal Health has also been active in capital management, reducing debt and completing share repurchases. In fiscal year 2026, the company completed an annual baseline share repurchase of $750 million [newsroom.cardinalhealth.com/2026-02-05-Cardinal-Health-Reports-Second-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook], and by the third quarter, additional share repurchases brought the fiscal year total to $1.0 billion [newsroom.cardinalhealth.com/2026-04-30-Cardinal-Health-Reports-Third-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook]. The company also announced an increase in its fiscal year 2026 non-GAAP adjusted free cash flow outlook to $3.0 to $3.5 billion [newsroom.cardinalhealth.com/2025-10-30-Cardinal-Health-Reports-First-Quarter-Fiscal-Year-2026-Results-and-Raises-Outlook], further solidifying its strong financial position and commitment to shareholder returns.

Partnerships

Cardinal Health Partnerships, Clients and Vendors

Cardinal Health actively engages in strategic partnerships and collaborations to enhance its healthcare solutions and supply chain capabilities. Notable technology integrations include a partnership with Palantir Technologies Inc. to develop a clinically integrated supply chain solution [source]. Additionally, Cardinal Health leverages Kinaxis's RapidResponse platform to optimize digital supply chain planning and improve medical product visibility [source]. To further refine its supply chain, Cardinal Health also collaborates with FourKites for enhanced tracking and analytics of medical and pharmaceutical products in transit [source].

In the realm of pharmaceutical operations, Cardinal Health partnered with Chronicled to utilize a blockchain-powered solution on the MediLedger Network, aiming to improve pharmaceutical chargeback accuracy [source]. A significant enterprise client relationship includes a joint venture with CVS Caremark (now CVS Health) formed in 2013 to create the largest generic sourcing entity in the U.S., with both companies committing their sourcing and supply chain expertise [source].

Cardinal Health has also expanded its offerings through collaborations with other healthcare entities. Its Outcomes™ business collaborates with Signify Health to provide in-home clinical and medication management services [source]. For retail independent pharmacies, Cardinal Health launched modern commerce solutions powered by Square, offering integrated software tools and payment options to enhance operational efficiency [source].

Beyond technology and large-scale ventures, Cardinal Health has forged partnerships to broaden access to essential medical supplies, such as its collaboration with Abbott and Quidel Corporation to commercialize over-the-counter rapid COVID-19 tests [source]. The company also established a Connectivity Partner Program, entering agreements with companies including CardioPulmonary, CliniComp, Emergin, and Misys Healthcare Systems to improve data flow by interfacing Cardinal Health solutions with third-party hospital technologies [source]. This program, along with expanded capabilities announced in 2010, focuses on seamlessly integrating Cardinal Health's pharmaceutical distribution services with hospital pharmacy technologies for safer and more efficient medication dispensing [source].

Events

Cardinal Health Event Participations

Cardinal Health actively participates in a variety of events, including investor conferences, earnings calls, and industry-specific summits. They frequently present at significant financial conferences, such as the J.P. Morgan Healthcare Conference, the BofA Securities Health Care Conference, and the Leerink Partners Global Healthcare Conference, with scheduled appearances into 2026 [ir.cardinalhealth.com/events-presentations/default.aspx]. The company also hosts its own Investor Day, with the most recent one occurring in June 2025 [ir.cardinalhealth.com/events-presentations/events/event-details/2025/2025-Cardinal-Health-Investor-Day/default.aspx].

In addition to investor-focused events, Cardinal Health conducts quarterly earnings conferences to discuss financial results, such as the 3Q FY2026 and 4Q FY2025 earnings conferences [ir.cardinalhealth.com/events-presentations/events/event-details/2026/3Q-FY2026-Cardinal-Health-Inc-Earnings-Conference/default.aspx, ir.cardinalhealth.com/events-presentations/events/event-details/2025/4Q-FY2025-Cardinal-Health-Inc-Earnings-Conference/default.aspx]. These events provide stakeholders with insights into the company's performance and strategic direction.

Cardinal Health also plays a significant role in the independent pharmacy sector by hosting the Retail Business Conference (RBC). This annual gathering, which anticipates over 4,500 independent pharmacy owners, offers opportunities to hear from inspiring speakers, gain industry education from subject matter experts, and earn CE credits [rbc.cardinalhealth.com/mainevents, rbc.cardinalhealth.com/about-rbc]. The RBC is designed to help pharmacy owners find new ways to support patients and grow their businesses.

Furthermore, Cardinal Health organizes Oncology Summits to engage healthcare providers in oncology and specialty care. These summits facilitate live insight-gathering sessions where a wide variety of healthcare stakeholders discuss value-based care topics crucial for addressing customer needs [cardinalhealth.com/en/services/manufacturer/biopharmaceutical/commercialization/provider-engagement.html]. These specialized events underscore the company's commitment to market research and provider engagement within critical healthcare sectors.

Frequently Asked Questions

What is the strategic implication of Cardinal Health's consistent participation in investor conferences and its own Investor Day?

Cardinal Health's consistent participation in investor conferences and its own Investor Day events, scheduled into 2026, signals a proactive and transparent approach to investor relations. This engagement strategy aims to maintain strong communication with financial stakeholders, convey long-term strategic direction, and reinforce investor confidence in the company's financial health and future growth prospects.

What does Cardinal Health's recurring Retail Business Conference (RBC) indicate about its market focus?

Cardinal Health's annual Retail Business Conference (RBC), which anticipates over 4,500 independent pharmacy owners, indicates a strong strategic focus on supporting the independent pharmacy sector. This event provides education, industry insights, and CE credits, highlighting the company's commitment to strengthening this segment by helping pharmacy owners grow their businesses and support patients.

What does Cardinal Health's hiring for roles like Software Engineer and Data Analyst suggest about its strategic priorities?

Cardinal Health's active hiring for roles such as Software Engineer and Data Analyst, with anticipated closing dates into 2026, suggests a strategic investment in technology and data-driven capabilities. These hires indicate the company's focus on enhancing its internal infrastructure, modernizing operations, and leveraging data for improved efficiency and decision-making across its healthcare solutions and supply chain.

Despite a revenue decrease in FY2025, what financial signal from Cardinal Health suggests underlying strength?

Despite a 2% revenue decrease in fiscal year 2025, primarily due to OptumRx contract expirations, Cardinal Health demonstrated underlying financial strength through an 83% increase in GAAP operating earnings, reaching $2.275 billion. This significant rise in operating earnings, alongside $2.5 billion in adjusted free cash flow, indicates improved operational efficiency and profitability despite top-line challenges.

What does Cardinal Health's repeated raising of its FY2026 non-GAAP EPS guidance signify?

Cardinal Health's repeated raising of its fiscal year 2026 non-GAAP EPS guidance, from an initial $9.30-$9.50 to $10.70-$10.80 by 3Q FY2026, signifies a robust and improving financial outlook. This consistent upward revision indicates strong operational performance, favorable market conditions, or effective strategic execution, leading to increasingly positive growth expectations for the company.

How does the composition of Cardinal Health's leadership team, specifically Jason Hollar's background, inform its strategic direction?

Jason Hollar, Cardinal Health's CEO since 2022 and former CFO from 2020-2022, brings a strong financial background to the top leadership role. This suggests a strategic emphasis on financial discipline, capital management, and a data-driven approach to corporate development and operational efficiency as key pillars of the company's strategic direction.

What does Cardinal Health's GPO offerings like VitalSource™ and Cornerstone Rheumatology™ indicate about its customer value proposition for specialty practices?

Cardinal Health's provision of GPOs like VitalSource™ and Cornerstone Rheumatology™ to specialty physician practices indicates a value proposition centered on improving financial performance and operational efficiencies. By aggregating purchasing power, these GPOs offer negotiated pricing and healthcare contracts, directly addressing cost reduction and enhancing profitability for specialty clinics.

What is the strategic rationale behind Cardinal Health's partnerships with technology companies like Palantir, Kinaxis, and FourKites?

Cardinal Health's partnerships with technology companies like Palantir, Kinaxis, and FourKites are strategically aimed at enhancing its supply chain capabilities through advanced analytics, optimization, and visibility. These collaborations seek to develop clinically integrated supply chain solutions, improve digital supply chain planning, and enable enhanced tracking of medical and pharmaceutical products in transit, ultimately driving efficiency and resilience.

What does Cardinal Health's Intelogix™ Platform suggest about its future direction in pharmaceutical supply chain management?

The Cardinal Health™ Intelogix™ Platform, which leverages AI and machine learning, suggests a future direction focused on technologically advanced and data-driven pharmaceutical supply chain management. This platform aims to reshape the supply chain to ensure access to critical medications and reduce costs for health systems, indicating a commitment to innovation for efficiency and cost-effectiveness.

How does Cardinal Health differentiate itself from competitors like McKesson and Cencora in the pharmaceutical distribution market?

While Cardinal Health, McKesson, and Cencora all compete in pharmaceutical distribution, Cardinal Health differentiates itself through specific strategic partnerships and a broader portfolio that includes manufacturing and distributing medical products. For example, its joint venture with CVS Caremark for generic sourcing and its focus on GPOs for specialty practices highlight tailored offerings beyond core distribution that may attract specific segments.

What kind of competitive pressure does Medline exert on Cardinal Health, and in what specific area?

Medline exerts competitive pressure on Cardinal Health particularly in the development, manufacturing, and distribution of medical and surgical products. Both companies offer extensive lines of medical supplies, including anesthesia, infection control, and surgical equipment, suggesting competition around product breadth, quality, and distribution network capabilities in the medical products sector.

What does Cardinal Health's offering of Presource® Kitting Services reveal about its strategy for cost reduction in healthcare facilities?

Cardinal Health's Presource® Kitting Services and Solutions, offering custom and standard kits for surgeries, reveal a strategy for cost reduction in healthcare facilities by promoting efficiency and consolidation. By bundling components that are typically purchased and managed separately, these kits aim to improve cost-effectiveness for providers through streamlined procurement and inventory management.

Powered by ForesightIQ · Competitive intelligence from digital exhaust